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Abstract
Introduction: Optimal fluid management is crucial for patients who undergo major and prolonged surgery.
Persistent hypovolemia is associated with complications, but fluid overload is also harmful. We evaluated the
effects of a restrictive versus conventional strategy of crystalloid administration during goal-directed therapy in
high-risk surgical patients.
Methods: We conducted a prospective, randomized, controlled study of high-risk patients undergoing major
surgery. For fluid maintenance during surgery, the restrictive group received 4 ml/kg/hour and the conventional
group received 12 ml/kg/hour of Ringer’s lactate solution. A minimally invasive technique (the LiDCO monitoring
system) was used to continuously monitor stroke volume and oxygen delivery index (DO2I) in both groups.
Dobutamine was administered as necessary, and fluid challenges were used to test fluid responsiveness to achieve
the best possible DO2I during surgery and for 8 hours postoperatively.
Results: Eighty-eight patients were included. The patients’ median age was 69 years. The conventional treatment
group received a significantly greater amount of lactated Ringer’s solution (mean ± standard deviation (SD): 4, 335 ± 1,
546 ml) than the restrictive group (mean ± SD: 2, 301 ± 1, 064 ml) (P < 0.001). Temporal patterns of DO2Iw e r es i m i l a r
between the two groups. The restrictive group had a 52% lower rate of major postoperative complications than the
conventional group (20.0% vs 41.9%, relative risk = 0.48, 95% confidence interval = 0.24 to 0.94; P =0 . 0 4 6 ) .
Conclusions: A restrictive strategy of fluid maintenance during optimization of oxygen delivery reduces major
complications in older patients with coexistent pathologies who undergo major surgery.
Trial registration: ISRCTN: ISRCTN94984995
Introduction
Despite unquestionable advances in the field of perio-
perative care, morbidity and mortality are still high in
some groups of patients, particularly in elderly patients
with coexisting pathologies or low cardiorespiratory
reserve who undergo extensive and traumatic noncardiac
surgery [1,2]. Multiple organ dysfunction and sepsis are
complications frequently seen after surgery in such
patients [3,4].
Global perfusion is usually assessed by calculation of the
oxygen delivery index (DO2I). Imbalance between oxygen
delivery (DO2) and oxygen consumption (VO2) can
quickly result in irreversible damage to the cells [5]. Perio-
perative alterations in DO2 are closely correlated to the
development of multiple organ failure (MOF) and death
[6]. The fundamental principle underpinning goal-directed
therapy (GDT), better known in the field of perioperative
care as “hemodynamic optimization, “is the optimization
of tissue perfusion by manipulating stroke volume (SV),
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improve DO2 by using fluids, inotropes and red blood
cells.
Several randomized clinical trials and meta-analyses
have shown reductions in postoperative complications and
mortality rates when preemptive strategies aimed at opti-
mizing tissue perfusion were used in the perioperative per-
iod [6-21]. In the past, cardiac output (CO) and DO2
measurements and GDT were performed by means of pul-
monary artery catheters [6-10]. Less invasive methods are
now available. The esophageal Doppler-derived corrected
flow time is the parameter used most frequently [14-18].
Other measurements, such as SV and CO, obtained by
pulse contour analysis with a lithium indicator dilution
and pulse power analysis conducted using the LiDCO plus
system (Cambridge, UK) and a Vigileo monitor (Edwards
Lifesciences, Irvine, CA, USA) or continuous hemody-
namic monitoring with a PiCCO monitor (Philips Health-
care, Andover, MA, USA) have been incorporated into
clinical practice. High-risk surgical patients allocated to
postoperative GDT to attain DO2Io f6 0 0m l / m i n u t e / m
2
measured using the LiDCO system had fewer complica-
tions and shorter hospital stays [19].
Perioperative fluid management is a challenge for
anesthesiologists and intensivists. The optimal periopera-
tive fluid regimen for major noncardiac surgery is unclear.
Some authors have suggested that estimates of ongoing
fluid loss that needs to be replaced with crystalloid are cer-
tainly excessive [22], and a growing body of evidence
demonstrates better outcomes associated with more
restrictive fluid replacement strategies [22-29]. These stu-
dies were performed using basic monitoring of vital signs,
central venous pressure, urine output and body weight.
However, high-risk patients who have more traumatic
surgery are at a high risk of hypovolemia and cardiac dys-
function, which cannot be detected without more complex
monitoring. Moreover, these patients may benefit from
GDT. Therefore, in this study of high-risk surgical
patients, we evaluated the impact of a restrictive strategy
of fluid maintenance compared to a conventional regimen
on the incidence of major postoperative complications
during GDT aimed at optimizing DO2I and reducing
serum lactate levels. We also assessed the hemodynamic
and perfusion patterns associated with the two regimens.
Materials and methods
This prospective, randomized, controlled study was
approved by the Institutional Review Board at our insti-
tution and carried out in the operating room (OR) and
2 4 - b e dI C Uo fat e r t i a r yh o s p i t a l .T h i ss t u d yi sr e g i s -
tered as ISRCT N94984995. Informed consent was
obtained from each patient. Recruitment was inter-
rupted for one year because of lack of funding.
Patients undergoing elective surgery were admitted to
the study if their total risk score based a system adapted
from the American College of Cardiology/American
Heart Association guidelines was ≥3 points [30]. Two
points were given for high-risk surgery, one point for
intermediate-risk surgery and one point for each clinical
predictor (Table 1). Exclusion criteria were refusal of
consent, unplanned surgery, unavailability of ICU beds,
pregnancy, congestive heart failure (New York Heart
Association functional class IV), chronic renal failure
(preoperative creatinine > 2.0 mg/dl or need for dialysis),
acute myocardial ischemia prior to enrollment (acute
myocardial infarction within six months, evidence of a
risk of ischemia based on clinical symptoms or findings
of noninvasive tests), lithium therapy, or severe ventricu-
lar or supraventricular arrhythmia), life expectancy < 60
days and palliative treatment. The presence of one of two
trained anesthesiologists or intensivists trained in the
study procedures was mandatory, and patients were not
enrolled if this condition was not met.
Treatment algorithm
After admission and in the OR, an oxygen catheter (2 L/
minute), a central venous catheter and an arterial catheter
for measurement of mean arterial pressure (MAP) were
immediately placed, and samples were taken for baseline
blood tests. Measurements of hematocrit, sodium, arterial
and venous blood gases, and serum lactate were obtained
hourly during surgery, every 2 hours for 8 hours in the
ICU and 24 hours after ICU admission. Serum C-reactive
protein (CRP) and creatinine were measured after admis-
sion to the ICU and 24 hours afterward. Electrocardio-
gram (EKG), pulse oximeter and MAP readings were
monitored continuously during the study period. Acid-
base and hydroelectrolytic disturbances were corrected
according to routine procedures.
A minimally invasive technique utilizing the LiDCO™-
plus Hemodynamic Monitor system with lithium dilution
was applied to continuously monitor SV, CO, DO2Ia n d
systemic vascular resistance index. DO2Iv a l u e s ,S V ,
serum lactate and central venous oxygen saturation
(SCVO2) were recorded hourly. A bolus of 10 ml/kg of
0.9% saline was administered before the induction of
anesthesia in patients in the two groups. The patients
were then randomized, using sealed envelopes (in blocks
of 10), to one of the two groups: restrictive or conven-
tional fluid maintenance. The surgeons were blinded to
the treatment assignments. The conventional group
received 12 ml/kg/hour of lactated Ringer’ss o l u t i o na s
maintenance fluid during surgery, and the restrictive
group received 4 ml/kg/hour of the same solution.
An epidural catheter was inserted before surgery, and
10 ml of ropivacaine hydrochloride (0.25%) was delivered
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following drugs were used: midazolam 0.05 to 0.10 mg/
kg, propofol 2 mg/kg, sufentanil 0.3 to 0.5 μg/kg and
atracurium besylate 0.5 mg/kg. Fluid maintenance was
achieved by using a balanced technique involving isoflur-
ane, nitrous oxide and oxygen, as well as continuous
infusion of sufentanil (0.3 to 0.5 μg/kg/hour) and atracur-
ium (7 to 10 μg/kg/minute).
The treatment algorithm is shown in Figure 1. The
therapeutic goals for both groups were to keep hemo-
globin between 8 to 10 mg/dl, SaO2 > 94%, urine output
> 0.5 ml/kg/hour, core temperature > 36°C and DO2Ia s
close as possible to or > 600 ml/minute/m
2 by using
dobutamine beginning at 2.5 μg/kg/minute and progres-
sively increasing until the goal was reached. Dobutamine
administration was interrupted in the presence of prede-
fined adverse events such as persistent tachycardia (an
increase by 20% from baseline), hypotension unrespon-
sive to fluid challenge, angina and/or signs of myocardial
ischemia on the EKG.
Fluid responsiveness was tested after the induction of
anesthesia and whenever serum lactate increased to > 2.0
mEq/L for two consecutive measurements, diuresis
declined to < 0.5 ml/kg/hour for 2 hours or arterial pulse
pressure variation was ≥13%. Fluid responsiveness was
evaluated by assessing the response of SV to the infusion
of 250 ml of gelatin over 20 minutes. If SV increased by >
10%, fluid replacement was maintained to keep the SV at
the achieved value for ≥10 minutes.
In the ICU, both groups received 1.5 ml/kg/hour of lac-
tated Ringer’s solution as fluid maintenance. The thera-
peutic goals in the ICU were the same as in the OR. The
same treatment algorithm was used for 8 hours postopera-
tively. After this period, dobutamine was tapered and then
discontinued. In the ICU, the Physiological and Operative
Severity Score for the enUmeration of Mortality and
morbidity (POSSUM) and respective estimated mortality
rates were calculated [31]. The patient was defined as an
achiever a DO2I > 600 ml/minute/m
2 was attained at at
least one time point in the period between the start of
surgery and 8 hours after ICU admission.
Outcomes
Patients were followed until hospital discharge or for 60
days. An investigator who was unaware of patient group
allocation evaluated complications retrospectively by
analyzing the medical records and all radiological images
and laboratory tests. Major complications were defined
as any untoward medical event that prolonged hospitali-
zation, was life-threatening or caused death.
Anastomotic leakage and wound dehiscence were con-
sidered complications of tissue healing. Cardiac arrhyth-
mias with hemodynamic repercussions, need for
antiarrhythmic drugs and arterial hypertension that
required sodium nitroprusside for control and/or pro-
longed ICU stay were considered cardiovascular compli-
cations. Severe sepsis and septic shock were defined
according to the American College of Chest Physicians/
Society of Critical Care Medicine guidelines [32]. Centers
for Disease Control and Prevention definitions were used
to diagnose nosocomial infections. Pulmonary emboli
were confirmed by spiral computed tomography. Renal
Table 1 Risk scoring system (adapted from American









Other long surgical procedure associated with
large-volume




Head and neck 1
Intraperitonial or intrathoracic 1
Orthopedic 1
Clinical predictor
Age > 60 years old 1
Diabetes (defined as standard taking medication or
not)
1
Abnormal electrocardiogram (left ventricular
hypertrophy, left bundle branch block, ST-T
abnormalities and atrial fibrillation)
1
Low functional capacity (inability to climb one
flight of
stairs with a bag of groceries)
1
Arrhythmia (receiving drug therapy) 1
History of stroke 1
Arterial hypertension (difficult to control) 1
Compensated or previous decompensated
heart failure (defined as standard)
1
Angina (Canadian Cardiovascular Society
classification system class I or II) or previous infarct
or
Q waves, severe valvopathy (severe valvular
regurgitation
with reduced left ventricular function)
1
Chronic hepatic failure (defined as standard) 1
Chronic renal failure (preoperative creatinine > 2.0
mg/dl
or need for dialysis)
1
Chronic obstructive pulmonary disease (defined as
standard)
or severe respiratory illness resulting in functional
limitation
1
Patients undergoing elective surgery were admitted to the study if their total
score was ≥3 points based on a risk-scoring system adapted from the
American College of Cardiology/American Heart Association guidelines [30].
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n i n el e v e lb ym o r et h a nt w i c et h eb a s e l i n el e v e ld u r i n g
the postoperative period in patients with previously nor-
mal renal function. Gastrointestinal dysfunction was
defined as feeding intolerance for more than five days
after the operation or the need for parenteral nutrition.
Extubation failure was defined as failure to extubate
within the first 24 hours after the operation or the need
for reintubation within 72 hours after extubation.
Statistical analysis
The size of the sample was determined based on previous
data from our institution showing a morbidity rate of
56% in patients who received GDT during surgery [33].
To achieve a study power of 80% and a two-sided test
with a significance of 0.05, 56 patients in each group
were required in order to decrease the morbidity rate by
46%. The first statistical evaluation, in which we looked
for differences in primary outcomes, was scheduled for
when 50% of the planned number of patients were
enrolled. At this point, 29 patients were included in the
conventional group and 27 were in the restrictive group.
At the time of this evaluation, a 50% decrease in the rate
of major complications was noted, and a second interim
analysis was planned for when around 80% of the original
planned population was enrolled. At that point, statisti-
cally significant differences in major outcomes were iden-
tified and the study was terminated.
Continuous variables are presented as means ± standard
deviations or medians with 25% to 75% interquartile
ranges, and categorical variables are given as numbers and
percentages unless otherwise indicated. The Kolmogorov-
Smirnov test was used to verify the normality of distribu-
tion of continuous variables. Difference testing between
groups was performed using a two-tailed t-test and Fish-
er’s exact test as appropriate. Analysis of variance was
used for repeated measurements. When there were statis-
tically significant differences, the Bonferroni test was used
to detect at which time the differences occurred. The inci-
dence of complications and mortality rates were evaluated
Figure 1 Algorithm of treatment. Delta-PP = change in arterial pulse pressure variation; DO2 = oxygen delivery; Hb = hemoglobin; SatO2 =
oxygen saturation; SV = stroke volume.
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P < 0.05 was considered statistically significant.
Results
A total of 116 patients were evaluated for inclusion in the
study between February 2006 and July 2010. Eighty-eight
patients were randomized, 43 to the conventional group
and 45 to the restrictive group. Twenty-eight patients
were excluded because of the unavailability of a trained
anesthesiologist or intensivist (n = 25) or an ICU bed
(n = 1), acute myocardial infarction within six months of
study inclusion (n = 1) and arrhythmia (n = 1). Because
of technical problems, SV and DO2 data were not avail-
able for three patients (all in the restrictive group) in the
postoperative period (arrhythmia in one patient and loss
of an arterial line in two). Patients were included in the
analysis on an intention-to-treat basis.
Demographic and risk-scoring data from both groups
are shown in Table 2. No significant differences between
groups were found. The median age of the patients was
69 years. Pre-, intra- and postoperative data, therapeutic
interventions, and tissue perfusion variables are given in
Table 3. The conventional group received a significantly
greater amount of lactated Ringer’s solution (4, 335 ± 1,
546 ml) during surgery than the restrictive group (2,
301 ± 1, 064 ml) (Mea ± SD) (P < 0.001). However, the
restrictive group received a significantly greater amount
of colloid (1, 216 ± 814 ml) than the conventional
group (915 ± 559 ml) (P < 0.05). The mean doses of
dobutamine administered to the conventional and
restrictive groups, respectively, were 12.3 ± 7.3 μg/kg/
minute vs 10.9 ± 5.9 μg/kg/minute intraoperatively
(P = 0.32) and 9.5 ± 6.2 vs 8.0 ± 4.5 μg/kg/minute post-
operatively (P = 0.19). There were 26 achievers (60.4%)
in the conventional group and 18 (40%) in the restrictive
group during surgery (P = 0.089). After surgery, a larger
number of patients in both groups achieved the thera-
peutic goals (31 (73.0%) vs 28 (62.2%); P = 0.39).
Temporal patterns of DO2I were similar between the
two groups. After an initial decline following anesthesia
induction, DO2I recovered similarly in both groups
(Figure 2). The P value for the treatment vs time interac-
tion was < 0.0001. DO2I levels were maintained at levels
higher than baseline most of the time in both groups.
Patterns of DO2I were also similar in patients with or
without complications, regardless of group assignment
(data not shown). Serum lactate and pH did not differ
between groups at baseline, ICU admission or 24 hours
after surgery (Table 3). SCVO2 values were similar at
baseline and ICU admission but significantly lower in the
restrictive group (72 ± 9) than in the conventional group
(76 ± 8) after 24 hours (P < 0.05).
Table 2 Baseline characteristics of patients in the conventional and restrictive groups
Patient characteristics Conventional group Restrictive group
Number of patients 43 45
Males (%) 24 (55.8) 21 (47.0)
Age, years 68.6 ± 7.3 69.2 ± 9.0
Cancer 29 (67.4) 33 (73.3)
Risk score, points 4 [3 to 4] 3 [3 to 4]
P-POSSUM physiological score 24 [20 to 27] 22 [18 to 27]
P-POSSUM operative score 15 [11 to 17] 15 [14 to 15]
Predicted morbidity rate 61.5 [52.7 to 82.3] 61.7 [45.7 to 82.4]
Predicted mortality rate 14.6 [11.2 to 38.2] 14.5 [9.1 to 28.9]
Clinical predictors
Age > 60 years 38 (88.3) 40 (88.8)
Arterial hypertension (difficult to control) 27 (62.7) 27 (60.0)
COPD 4 (9.3) 4 (8.8)
Diabetes 4 (9.3) 4 (8.8)
EKG alterations 4 (9.3) 4 (8.8)
Previous AMI 1 (2.3) 3 (6.6)
Previous CVA 2 (4.6) 0 (0)
Type of surgery
Colorectal 30 (69.7) 38 (84.4)
Vascular 10 (23.2) 4 (8.8)
Orthopedic 2 (4.6) 2 (4.4)
Other 1 (2.3) 1 (2.2)
AMI = acute myocardial infarction; COPD = chronic obstructive pulmonary disease; CVA = cardiovascular accident; EKG = electrocardiogram; P-POSSUM =
Portsmouth predictor equation-modified Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity; SD = standard deviation.
Data a presented as n (%), mean ± SD or median [25% to 75% interquartile range]. There were no significant differences between groups.
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fluid challenge. In the conventional group, 104 fluid
challenges were performed, of which 58.6% were posi-
tive. In the restrictive group, 143 fluid challenges were
performed, of which 65% were positive (Table 3).
T h e r ew e r en od i f f e r e n c e si np u l m o n a r yo rr e n a lf u n c -
tion between groups at any time (Table 4). Serum levels
of CRP for the conventional and restrictive groups were
2.0 ± 2.5 mg/dl and 2.1 ± 2.4 mg/dl after admission to
the ICU, respectively (P = 0.97). Twenty-four hours after
admission to the ICU CRP levels were 12.0 ± 5.5 mg/dl
in the conventional group and 11.9 ± 6.5 mg/dl in the
restrictive group (P = 0.94).
In the restrictive group, the rate of major postopera-
tive complications was 52% less than in the conventional
group (20.0% vs 41.9%, RR = 0.48, 95% CI = 0.24 to
0.94; P = 0.046) (Table 5). The 60-day mortality rates
were 6.9% in the conventional group and 2.2% in the
restrictive group (not significant).
Discussion
This study is the first in which the effects of two different
regimens of fluid maintenance in the setting of GDT and
optimization of DO2 have been investigated. The main
finding of our study is that there were significantly fewer
major complications, particularly with regard to tissue
healing and cardiovascular events, in high-risk patients
m a n a g e dw i t hG D Ta n dam o r er e strictive fluid strategy
during major surgery, compared to those managed with a
more liberal fluid strategy. Infusion of 4 ml/kg/hour com-
pared to 12 ml/kg/hour of lactated Ringer’ss o l u t i o na s
maintenance fluid during GDT with DO2- and lactate-
guided optimization reduced the incidence of major com-
plications by 52%.




Operation time, minutes 228 ± 53 250 ± 60
Crystalloid, ml 4, 335 ± 1, 546 2, 301 ± 1, 064**
Colloid, ml 915 ± 559 1, 216 ± 814*
Fluid-challenged patients 42 (97.7) 44 (97.7)
Fluid challenges per patient 2.4 3.1
Positive fluid challenges 61 (58.6) 93 (65.0)
Transfused patients (RBCs) 18 (41.8) 19 (42.2)
RBCs, units 1.8 ± 0.4 1.9 ± 0.9
Dobutamine doses, μg/kg/minute 12.3 ± 7.3 10.9 ± 5.9
Achievers 26 (60.4) 18 (40.0)
Postoperative
Crystalloid, ml 1, 296 ± 1114 1, 145 ± 680
Colloid, ml 1, 321 ± 595 1, 210 ± 700
RBC transfusions 10 (23.2) 11 (24.4)
RBCs, units 1.7 ± 0.7 1.5 ± 0.5
Dobutamine dose, μg/kg/minute 9.5 ± 6.2 8.0 ± 4.5
Tissue perfusion
Preoperative
Serum lactate, mEq/L 1.3 ± 0.4 1.3 ± 0.5
SCVO2, % 72 ± 7 71 ± 7
pH 7.39 ± 0.05 7.41 ± 0.04
ICU admission
Serum lactate, mEq/L 2.51 ± 1.1 2.6 ± 1.2
SCVO2, % 72 ± 10 74 ± 10
pH 7.32 ± 0.06 7.32 ± 0.07
24 hours after ICU admission
Serum lactate, mEq/L 1.9 ± 0.8 2.0 ± 0.9
SCVO2, % 76 ± 8 72 ± 9*
pH 7.39 ± 0.05 7.3 5 ± 0.05
Achievers 31 (73.0) 28 (62.2)
RBC = red blood cell; SCVO2 = central venous oxygen saturation; SD = standard deviation. Data are presented as absolute values, n (%) or means ± SD. *P < 0.05
vs conventional group. **P < 0.01 vs conventional group.
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the administration of large amounts of crystalloid, causing
weight increases of 3 to 6 kg [22]. There is a dose-response
relationship between complications and increasing body
weight on the day of surgery. Positive fluid balance has
been associated with more complications and increased
mortality in medical and surgical patients admitted to
ICUs [34-36].
Interventional studies have compared restrictive regi-
mens of fluid maintenance using more liberal strategies.
In a randomized controlled study of 172 patients under-
going colorectal surgery, Brandstrup et al. [22] showed
that not replacing fluid loss to the third space and not
giving a volume preload prior to epidural anesthesia was
associated with a significant decrease from 56% to 30%
in postoperative morbidity. In this study, patients in the
restrictive group received 3, 200 ml of fluid compared
to 6, 200 ml in the liberal group [22]. Nisanevich et al.
[23] compared 4 ml/kg/hour with 12 ml/kg/hour of
fluid maintenance during gastrointestinal surgery and
reported a similar impact on outcomes. In another
study, administration of a median of 3, 000 ml com-
pared to 6, 300 ml of fluid reduced complications and
length of stay in the hospital after colorectal surgery
[26]. Restrictive fluid regimens have also been associated
with better outcomes in patients undergoing vascular
surgery [28,29].
Our study corroborates the findings of these previous
publications. It is important to note, however, that, in con-
trast to our study, these earlier studies were performed in
low-risk patients and GDT was not applied simultaneously
with surgery. One recent publication compared two strate-
gies of fluid maintenance, 6 ml/kg/hour of crystalloid in
the restrictive group and 12 ml/kg/hour of crystalloid in
the conventional group, integrated with GDT in patients
undergoing major surgery [36]. In both groups in that
study, a fluid bolus was administered when respiratory
variation in peak aortic flow velocity was > 13%, which
was considered indicative of hypovolemia. The incidence
of hypovolemia and postoperative complications, especially
anastomotic leak and sepsis, was higher in the restrictive
group than in the conventional group. Although these
Figure 2 Temporal patterns. Temporal patterns of oxygen delivery (DO2) during surgery and postoperatively for the restrictive group (black
triangles) and the conventional group (black squares). The results are presented as means and standard errors of the mean. 0, preoperative; 1,
30 minutes intraoperatively (IO); 2, 60 minutes IO; 3, 120 minutes IO; 4, 180 minutes IO; 5, 240 minutes IO; 6, 300 minutes IO; 7, 360 minutes IO;
8, 420 minutes IO; 9, 480 minutes IO; 10, ICU admission; 11, 1 hour postoperatively (PO); 12, 2 hours PO; 13, 3 hours PO; 14, 4 hours PO; 15, 5
hours PO; 16, 6 hours PO; 17, 7 hours PO; 18, 8 hours PO. Treatment × time interaction; P < 0.0001.
Table 4 Renal and pulmonary function in conventional
and restrictive groups
Renal and pulmonary function Conventional Restrictive
Before surgery
Creatinine, mg/dl 1.0 ± 0.4 0.9 ± 0.3
PO2/FiO2 ratio 438 ± 220 436 ± 187
ICU admission
Creatinine, mg/dl 0.9 ± 0.5 1.1 ± 1.2
PO2/FiO2 ratio 335 ± 174* 337 ± 173*
24 hours after surgery
Creatinine, mg/dl 1.2 ± 0.7 1.0 ± 0.3
PO2/FiO2 ratio 260 ± 129** 248 ± 109**
PO2/FiO2 ratio = ration of arterial oxygen pressure to fraction of inspired
oxygen; SD = standard deviation. All data are means ± SD. *P < 0.05 vs before
surgery; **P < 0.01 vs before surgery.
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flow-related parameter, DO2 was not a target, making
direct comparisons with our study difficult.
There are two fundamental aspects of GDT in high-risk
surgical patients that must be considered. First, hypovole-
mia is very common in surgical patients and cannot be
detected by routine monitoring of blood pressure, heart
rate and central venous pressure. Reduced effective circu-
lating volume may cause various deleterious effects by
redirecting flow away from the gut, kidneys and other
organs, leading to MOF. At the other extreme, fluid over-
load in critically ill patients has been associated with var-
ious adverse effects, such as prolonged mechanical
ventilation, pulmonary edema, abdominal compartment
syndrome, infection, longer stay in the ICU and more
complications after diverse types of surgery. Therefore,
one important component of GDT is to test fluid respon-
siveness with fluid challenges to minimize the risk of
hypo- or hypervolemia. Fluid responders are able to con-
vert fluid loading into a significant increase in CO.
Many studies of GDT have used successive fluid chal-
lenges as the main tool of the GDT strategy and have
shown improved outcomes mainly as decreased compli-
cation rates [12-20]. In older patients, however, fluid
challenge unresponsiveness is not infrequently related to
myocardial dysfunction or intolerance to fluids. In our
study, all but one patient in each group had signs of
hypovolemia during surgery as defined by the treatment
algorithm. Patients in the restrictive group received
more fluid challenges (3.1 per patient) than did patients
in the conventional group (2.4 per patient). However,
the number of fluid responders was similar between the
two groups, demonstrating that although patients in the
conventional group received more crystalloid, it did not
prevent further signs of hypovolemia, which is likely a
reflection of cardiac dysfunction.
Table 5 Major complications in conventional and restrictive groups
Complications and outcomes Conventional (n = 40) Restrictive (n = 41)
Total complications 43 45
Cardiovascular complications
Atrial fibrillation 2 (4.6) 1 (2.2)
Hypertensive crisis 4 (9.3) 0 (0)
Pulmonary thromboembolism 0 (0) 1 (2.2)
Total 6 (13.9) 2 (4.4)
Tissue-healing complications
Evisceration 2 (4.6) 0 (0)
Anastomotic leak 2 (4.6) 1 (2.4)
Total 4 (9.3) 1 (2.4)
Infectious complications
Nosocomial pneumonia 4 (9.3) 6 (13.3)
Occult septic shock 1 (2.3) 0 (0)
Peritonitis 2 (4.6) 0 (0)
Blood stream infection 0 (0) 1 (2.2)
Wound abscess 2 (4.6) 0 (0)
Total 9 7
Other complications
Extubation failure 1 (2.3) 0 (0)
Renal dysfunction 1 (2.3) 0 (0)
Gastrointestinal dysfunction 3 (6.9) 1 (2.2)
Total 5 1
Total number of major complications 24 11
Number of patients with complications 18 (41.8) 9 (20.0)*
Number of complications per patient 0.55 0.24
Outcomes
LOS in the ICU 2.0 [1.0 to 4.0] 2.0 [2.0 to 5.0]
LOS in the hospital 6.0 [4.0 to 9.0] 6.0 [4 to 10]
30-day mortality rate 2 (4.6) 0 (0)
60-day mortality rate 3 (6.9) 1 (2.2)
LOS = length of stay. Data are presented as absolute values, n (%) or medians [25% to 75% interquartile range].
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patients is to prevent an imbalance between DO2 and
VO2 to avoid multiple organ dysfunction. Many
researchers have used dobutamine to achieve higher
levels of DO2I or cardiac index during prolonged sur-
gery and have reported reduced morbidity and mortality
[6-11]. One key difference between our study and the
s t u d yb yF u t i e ret al. [37], apart from the different goal
of therapy, is the use of dobutamine. The fact that in
our study there were fewer fluid responders suggests
that our population had more contractility problems,
which is consistent with the older median age of our
group. Dobutamine may increase tolerance to fluids and
prevent cardiac dysfunction [33]. These data suggest
that dobutamine may be important in this group of
patients and that DO2 m a yb eam o r ea p p r o p r i a t eg o a l
for hemodynamic optimization therapy in high-risk
patients.
Edema of the intestines and other tissues may be
responsible for poor tissue healing and other complica-
tions. Gut edema may be associated with postoperative
gastrointestinal dysfunction, impaired tissue oxygenation
and increased intraabdominal pressure. The use of less
crystalloid associated with more colloid, by protecting the
gut from gastrointestinal dysfunction, may explain the
reduced complication rate in the restrictive group. In
experimental models, colloid increases microcirculatory
blood flow and tissue oxygen tension in the gut mucosa
[38]. In a model of gut ischemia in rabbits, crystalloid
administration was associated with more gut edema than a
combination of colloid with less crystalloid [39]. Patients
in the restrictive group received more fluid challenges (3.1
per patient) than did patients in the conventional group
(2.4 per patient). As a consequence, they received more
colloid. It is possible that the fluid challenges rather than
the overall fluid balance benefit patients the most.
It is now recognized that around 15% of patients under-
going surgery are at high risk of complications and death
[40]. Factors associated with increased risk include older
age, the presence of comorbid disease and major surgical
procedures. In the present study, patients had a median of
four comorbidities and a median age of 70 years. Research-
ers in previous studies have published morbidity rates as
high as 70% in similar groups of patients. A previous study
in Brazilian ICUs reported morbidity and mortality rates of
38% and 20%, respectively, in unselected surgical patients
[4]. Major complications occurred in 32% of patients in an
Australian study with a mortality rate of 2% [41]. The low
morbidity and mortality, despite higher rates predicted on
the basis of POSSUM scores, suggests that the preemptive
use of GDT with fluids and inotropes targeting DO2
improves survival in this group of surgical patients.
Our study has strengths and limitations. First, the
v o l u m eu s e da sm a i n t e n a n c ef l u i dm a yb ec o n s i d e r e d
too liberal. We deliberatelyc h o s eac o n v e n t i o n a lf l u i d
regimen that reflects current clinical practice for fluid
administration during major surgical procedures. Text-
books and guidelines indicate a need for 10 to 15 ml/
kg/hour of crystalloids as maintenance fluid in addition
to the replacement of blood loss during major and pro-
longed surgery. The basis for this standard recommen-
dation is an assumed large intravascular volume deficit
caused by evaporative loss, fasting and third spacing, all
to be replaced by crystalloids. More recent studies have
actually shown that extracellular volume expands rather
than contracts with fluid balance [42]. Despite earlier
studies and several clinical guidelines suggesting benefits
associated with a more restrictive or net even approach
to fluid therapy, this strategy is still not widely used.
Second, this study was performed in only one tertiary
center, and its results may not be applicable to other
centers. Third, the inability to include consecutive
patients because of the limited number of anesthesiolo-
gists trained in the procedures used in the study is also
a limitation. The main strength of our study is its ran-
domized controlled design and the homogeneous group
of high-risk surgical patients.
Conclusions
Perioperative hemodynamic GDT with a protocol incor-
porating restrictive fluid maintenance and inotropic
therapy to achieve the best possible DO2 in very high-
risk surgical patients can be easily performed with the
use of minimally invasive hemodynamic monitoring to
obtain continuous monitoring of CO and is related to
better patient outcomes. It is possible that with more
reliable and easy-to-use hemodynamic monitoring dur-
ing anesthesia, fluid maintenance volumes might be
safely reduced.
Key messages
◆ Morbidity and mortality are high in some groups
of patients, particularly elderly patients with low car-
diorespiratory reserves who undergo extensive non-
cardiac surgery.
◆ Perioperative alterations in DO2 are closely corre-
lated to the development of MOF and death.
◆ Randomized clinical trials have shown reductions
in postoperative complications and mortality rates
when strategies aimed at optimizing tissue perfusion
are used in the perioperative period.
◆ The optimal perioperative fluid regimen for major
noncardiac surgery patients is unclear.
◆ The preemptive use of GDT with fluids and ino-
tropes targeting DO2 and a more restrictive strategy
of fluid maintenance during surgery leads to fewer
major complications in high-risk patients undergoing
major surgery.
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